- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02731976
Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge
April 8, 2016 updated by: Alexandra Zhernakova, University Medical Center Groningen
The Influence of a Short-term Gluten-free Diet on the Human Gut Microbiome
Changes in the gut microbiomes of healthy volunteers who followed a gluten-free diet (GFD) for four weeks were studied.
Per participant, nine stool samples were collected: one at baseline, four during the GFD period, and four when they returned to their habitual diet.
Microbiome profiles were determined using 16S rRNA sequencing and the samples were next processed for taxonomic and imputed functional composition.
Additionally, participants kept a 3-day food diary and six gut health-related biomarkers were measured.
Study Overview
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Groningen, Netherlands, 9700 RB
- University Medical Center Groningen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy participants aged >=16
Exclusion Criteria:
- Known gastrointestinal disorder
- Known food intolerance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: GFD
After instruction of a dietician, participants adhered to a gluten-free diet for 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in gut microbiota composition upon gluten-free diet intervention
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in gut associated biomarker levels: fecal calprotectin
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: IL-1beta
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal human beta defensin 2
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal chromogranin A
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal short chain fatty acids: propionate
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma citrulline
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal short chain fatty acids: acetate
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal short chain fatty acids: butyrate
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal short chain fatty acids: valerate
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: fecal short chain fatty acids: caproate
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: IL-6
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: IL-8
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: IL-10
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: IL-12
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Changes in gut associated biomarker levels: plasma cytokines: TNFalpha
Time Frame: baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (ACTUAL)
February 1, 2012
Study Completion (ACTUAL)
May 1, 2014
Study Registration Dates
First Submitted
April 4, 2016
First Submitted That Met QC Criteria
April 4, 2016
First Posted (ESTIMATE)
April 8, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
April 11, 2016
Last Update Submitted That Met QC Criteria
April 8, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- M12.113965
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Microbiome
-
University of AarhusAarhus University Hospital; University of Copenhagen; Arla FoodsActive, not recruitingBreast Milk Collection | Infant Gut Microbiome | Human Milk/Breastfeeding | Human Milk MicrobiomeDenmark
-
Integrative Skin Science and ResearchVerdure SciencesCompletedHuman MicrobiomeUnited States
-
Seoul National University HospitalCompletedHuman MicrobiomeKorea, Republic of
-
VA Office of Research and DevelopmentCompletedHuman MicrobiomeUnited States
-
NYU Langone HealthWithdrawn
-
Integrative Skin Science and ResearchMicrobiome labsNot yet recruitingHuman MicrobiomeUnited States
-
DaniscoReprocell Inc; SerologixCompletedHuman MicrobiomeUnited States
-
Integrative Skin Science and ResearchSytheon Ltd.CompletedHuman MicrobiomeUnited States
-
The University of The West IndiesJ. Craig Venter InstituteCompletedHuman Microbiome
-
Seoul National University HospitalCompletedHuman MicrobiomeKorea, Republic of
Clinical Trials on Dietary intervention
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University Hospital, Strasbourg, FranceRecruitingDigestive Cancer | UndernourishedFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of South CarolinaAcademy of Nutrition and DieteticsCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedCaloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast CancerBreast Carcinoma | Endometrial Carcinoma | Prostate CarcinosarcomaUnited States